Kinled

Kinled is a family office investment firm headquartered in Zurich, Switzerland, that manages family capital and pursues venture and early-stage opportunities. It invests across technology, life sciences and healthcare, digital health, software as a service, fintech, mobile commerce, and related sectors, with exposure to European and Asian markets. The firm supports portfolio companies toward growth and has a track record of successful exits, including public listings and strategic sales.

Rupert Novis

CEO and Director

108 past transactions

Xapien

Seed Round in 2023
Xapien is a developer of an artificial intelligence-based online research platform focused on third-party risk management. The company leverages advanced technologies such as artificial intelligence and natural language processing to automate the research process, providing on-demand insights about individuals and companies worldwide. By enhancing clients' internal research capabilities, Xapien delivers comprehensive and context-rich information that aids in informed decision-making. This innovative approach not only streamlines research efforts but also reduces costs associated with internal and outsourced research, giving clients a competitive edge in managing risks effectively.

Connect Earth

Seed Round in 2023
Founded in 2021, Connect Earth is a London-based environmental data company that democratizes access to sustainability data. It offers a carbon tracking API technology to empower individuals and institutions to make sustainable choices by providing transparent insights into the climate impact of daily spending.

OneTrust

Venture Round in 2023
OneTrust develops a comprehensive technology platform for privacy management. It automates privacy impact assessments, data inventory mapping, consent management, subject rights requests, incident reporting, and vendor risk management. The platform enables businesses to comply with global data privacy regulations across various sectors and jurisdictions.

Nanoflex Robotics

Series A in 2023
Founded in 2021, Nanoflex Robotics is a MedTech company developing a telerobotic platform for remote Mechanical Thrombectomy, enabling faster treatment of ischemic strokes. This improves patient outcomes, boosts hospital profitability, and enhances health equity. The platform uses magnetic navigation technology, ultra-flexible microrobotics, and AI-compatible software, allowing precise remote procedures.

hi.health

Venture Round in 2023
hi.health is a health‑insurance technology company that streamlines the claims process for private insurers. It offers co‑branded debit cards that members can use worldwide at health‑related facilities, eliminating out‑of‑pocket expenses and reducing claim friction. The platform aggregates digital services, invoices, and prescriptions, providing insurers with real‑time data, structured cost visibility, and fraud controls. By integrating payment and insurance functions, hi.health helps insurers improve member experience, cut operational and fraudulent costs, and encourage cost‑conscious behavior through reward and cashback programs.

Algonist Biotechnologies

Venture Round in 2023
Algonist Biotechnologies is a pre-clinical stage biotechnology company focused on developing novel small molecule therapeutics for treating chronic pain. It specializes in creating oral drugs that aim to improve efficacy and reduce side effects compared to current treatments.

CEBINA Bridge Capital

Seed Round in 2023
Established in 2021, CEBINA Bridge Capital is a venture capital firm headquartered in Gibraltar. It focuses on investing in pharmaceutical drug discovery and biotech projects within Central and Eastern Europe.

Five Lives

Seed Round in 2022
Five Lives is a London-based digital therapeutics company focused on enhancing brain health through its innovative mobile application, Sharp. The platform is designed to assist users in measuring and managing their cognitive health, ultimately aiming to reduce the risk of cognitive decline. By providing an engaging and user-friendly tool, Five Lives empowers individuals to adopt healthier lifestyles, thereby improving their overall well-being and extending their quality of life. This proactive approach aims to facilitate earlier detection of dementia and promote long-term cognitive health for users.

Ahead App

Venture Round in 2022
Master your emotions in 5 minutes a day. Ahead is a personalized pocket coach that provides bite-sized, science-driven tools to boost emotional intelligence. Think of it as a pocket cheerleader towards a better, more fulfilling, clearer-minded way of life. Most of us continuously set goals for our life - for our career, our relationships, our health. Yet, it’s damn hard to turn those goals into reality! We know - we’ve been there ourselves. That’s why we know there’s a way to make it work. And that’s what aHead is all about! Get early access: ahead-app.com

PreComb

Seed Round in 2022
PreComb develops advanced technologies to adapt cancer therapies to individual patients, aiming to enhance treatment success rates and improve patient outcomes.

Tridek-One

Venture Round in 2022
Tridek-One is a biotechnology company focused on developing immunomodulatory products aimed at addressing auto-immune and inflammatory disorders. The company's primary product is a peptide designed to maintain a cluster of truncated CD31 molecules at the membrane, which helps moderate overactive immune responses without complete blockade. By facilitating improved treatment options for medical companies, Tridek-One seeks to enhance the quality of life for patients suffering from these conditions.

OctaiPipe

Angel Round in 2022
OctaiPipe specializes in Federated Learning Operations (FL-Ops) for Edge AIoT devices. It streamlines the entire lifecycle of developing distributed IoT solutions, enabling data scientists to create scalable, adaptable systems while minimizing monitoring and maintenance costs.

Accelus

Series D in 2022
Accelus specializes in developing medical implants aimed at enhancing minimally invasive spine surgery. The company focuses on expandable interbody technology, offering a bi-directional expandable cage that combines the strength and rigidity of a traditional monolithic implant. This innovative design allows healthcare professionals to effectively address various spinal issues, including height, weight, and lordosis problems. Accelus is dedicated to improving access to its advanced surgical solutions, particularly in markets that have been historically underserved.

Adsum

Seed Round in 2022
Adsum is a London-based fintech company established in 2020, focusing on providing instant value-added tax refunds and tax credits for UK businesses. The company has developed a software infrastructure that facilitates immediate VAT refunds through embedded software integrations with partner organizations. Utilizing artificial intelligence and machine learning, Adsum simplifies the tax credit process, helping businesses reduce human error and enhance growth. By specializing in R&D and Creative Industry Tax Credits, Adsum aims to deliver value-added services that support the financial needs of its clients.

BVNK

Series A in 2022
BVNK offers modern payment infrastructure for businesses. It unifies banks and blockchain networks on a single platform, allowing companies to send and receive stablecoin payments, convert currencies, and integrate crypto payments into their checkout processes. BVNK's flexible platform enables innovators to launch new payment products swiftly while ensuring compliance.

Engimmune Therapeutics

Seed Round in 2022
Developer of biotechnology research company designed for the next generation of T cell receptor therapies against cancer. The company engages in the development of TCR-based immunotherapies including T-cell therapies and biologics combining genome editing, functional high-throughput screening, deep sequencing, and machine learning, addressing key efficacy and safety challenges, enabling patients to get the treatment of serious diseases with high unmet medical need.

Memo Therapeutics

Series B in 2022
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Wiredirect

Series A in 2022
Wiredirect is a global financial technology and FX liquidity firm that has built a whole new way to make payments across borders.

CEBINA

Venture Round in 2022
CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies and develops cutting-edge biotech projects.

Opal

Seed Round in 2022
Opal develops a digital control application that helps users manage screen time by taking control of their phones and disconnecting distracting apps across operating systems and web browsers. The app tracks time saved, provides real-time feedback and rewards, and aims to reclaim time to improve productivity and mental health. It serves individuals and teams, including startups and large organizations, seeking to protect focus and reduce distractions.

Lapse

Seed Round in 2021
Lapse is a social disposable camera application that allows users to capture and share photos in a nostalgic format reminiscent of traditional disposable cameras. The app facilitates private group chats where users can take up to 36 snapshots, creating a "roll" that is only accessible to group members for a limited time after the first image is taken. This design encourages spontaneity and a sense of shared experience among friends, promoting an engaging way to document moments together while maintaining privacy.

Acrivon Therapeutics

Series B in 2021
Acrivon Therapeutics is a clinical-stage biopharmaceutical company focused on developing precision oncology therapeutics. The company employs a proteomics-based platform to identify patients whose tumors are likely to respond positively to specific treatments, thereby enhancing the effectiveness of its drug development efforts. Acrivon's pipeline features its lead program, ACR-368 (prexasertib), which is currently in Phase 2 trials, alongside several preclinical programs targeting key components of DNA damage response and cell cycle regulation, including WEE1 and PKMYT1. By concentrating on complex oncology drug targets that are often not addressed by traditional therapies, Acrivon aims to expedite the advancement of both in-licensed clinical-stage assets and its internally developed programs through accelerated registration trials.

Cobee

Series A in 2021
Founded in 2018, Cobee is a Madrid-based company specializing in employee benefits management. Its online platform automates and simplifies benefits administration, offering flexible compensation options to enhance employee satisfaction while reducing costs for companies.

FERNRIDE

Series A in 2021
FERNRIDE specializes in scalable automation solutions for yard trucking. Their human-assisted autonomy approach enhances productivity, worker safety, and sustainability. With over a decade of research and prominent clients like Volkswagen, HHLA, and DB Schenker, FERNRIDE addresses industry challenges such as driver shortages and environmental impact.

Alentis Therapeutics

Series B in 2021
Alentis Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for cancer and fibrotic diseases, including liver fibrosis, cirrhosis, and liver cancer. It pursues CLDN1-targeted approaches, developing anti-CLDN1 antibodies and antibody-drug conjugates to modify disease progression in CLDN1-positive cancers. Founded in 2019 and based in Basel, Switzerland, the company advances programs that aim to modulate the immune response and enhance anti-tumor activity while addressing liver-related conditions.

Hummingbird Bioscience

Series C in 2021
Hummingbird Bioscience employs systems biology to uncover disease mechanisms and uses computational platforms for discovering and engineering innovative biotherapeutics. Its pipeline includes HMBD-001 (anti-HER3 antibody) and HMBD-002 (anti-VISTA antibody), both in cancer treatment. The company collaborates strategically with Cancer Research UK and Amgen.

Sylvera

Seed Round in 2021
Sylvera is a carbon data provider based in London, United Kingdom, established in 2020. The company specializes in developing machine learning-based tools to monitor the performance of carbon offset projects. These tools enable remote tracking of project performance at intervals of up to a week, facilitating the integration of carbon data into both internal and external reporting frameworks. By offering enhanced transparency around carbon offsets, Sylvera aims to assist businesses and governments in reducing reputational risks associated with carbon emissions, ultimately promoting real-world climate action.

Receeve

Seed Round in 2021
Receeve offers a digital debt recovery platform powered by AI. It streamlines operations for businesses, financial institutions, and funds, enhancing efficiency and transaction transparency.

PreComb

Seed Round in 2021
PreComb develops advanced technologies to adapt cancer therapies to individual patients, aiming to enhance treatment success rates and improve patient outcomes.

Gitpod

Venture Round in 2021
Gitpod is an open-source developer platform that automates the provisioning of ready-to-code development environments for cloud-based applications. It eliminates setup friction by delivering prebuilt workspaces and enabling teams to start coding immediately for each new task, whether creating features, fixing bugs, or performing code reviews. The platform integrates with GitLab, GitHub, and Bitbucket and automatically prebuilds environments for all branches, treating environments as code to support automated provisioning, language engineering, modeling, diagramming, and parallel workspaces. This approach helps engineering teams focus on workflow and collaboration rather than environment setup.

Bob W

Seed Round in 2021
Bob W is a provider of short-stay accommodation services that offers an alternative to traditional hotels. The company operates a managed marketplace of serviced apartments that combine the quality standards and amenities of a lifestyle hotel with the authenticity and functionality of a home. Each apartment is locally designed, work-friendly, and equipped with hotel linens and professional cleaning services. Additionally, the accommodations feature fully equipped kitchens, access to local gyms, and curated breakfast options. This approach allows travelers to easily find and enjoy short-stay accommodations tailored to their needs while ensuring a high standard of service and ecological mindfulness.

Eirion Therapeutics

Series A in 2021
Eirion Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of advanced prescription products for aesthetic dermatology. The company's product pipeline includes treatments aimed at addressing various conditions such as wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. Eirion is committed to meeting significant unmet clinical needs within the field, with plans to explore additional indications in the future. Through its innovative approach, Eirion Therapeutics aims to provide effective solutions for both physicians and patients dealing with aesthetic concerns.

Muse Finance

Seed Round in 2021
Muse Finance is a technology platform designed to facilitate working capital solutions for B2B businesses. By integrating seamlessly with client operations, it provides end-to-end financing options that enhance user engagement and overall client experience. The platform offers a no-code and API integration, allowing businesses to implement white-label financial services rapidly. Muse Finance's offerings include three primary products: trade finance, buy now pay later for businesses, and invoice finance tailored for UK limited companies. Additionally, the platform features a real-time dashboard for businesses to manage client funding requests and monitor progress, alongside tools for cash flow forecasting and risk management. Ultimately, Muse Finance enables small businesses to optimize their financial operations and make informed decisions based on accurate credit insights and instant credit assessments.

cofenster

Seed Round in 2021
cofenster develops a suite of Video AI assistants that automate video production, enabling autonomous video creation and collaboration with communications, HR and marketing teams. The portfolio includes Milo, which transforms long videos into short clips; Ella, which generates authentic user-generated content; and Theo, which turns text into video. In addition, cofenster offers a smartphone-based video production application that guides users through planning, recording and post-production, automatically rendering and editing videos, adding subtitles and music, and incorporating corporate identity elements. The platform targets both large enterprises and small and medium-sized businesses, and has been adopted by corporate customers across sectors.

Herophilus

Series A in 2021
Herophilus is a biotechnology company focused on developing innovative neurotherapeutics aimed at treating brain disorders. The company utilizes advanced techniques, including human brain models, scaled biology, and machine learning, to systematically identify and develop novel drugs with therapeutic potential. By employing phenotypic screening, Herophilus aims to discover new treatments for complex neurological and psychiatric conditions such as epilepsy, autism, and schizophrenia. Their mission is to enable healthcare professionals to offer effective treatments for patients suffering from these disorders, ultimately assisting individuals in managing the emotional and cognitive symptoms associated with neurological issues.

HomeHero

Venture Round in 2021
HomeHero is a digital home manager that consolidates household bills and services and provides an operating system for the home built on cloud-based architecture integrated with mobile and IoT technologies. The platform collects and organizes all bills in one place, supports maintenance reporting and service bookings such as boiler repairs and cleaners, and handles administrative tasks such as package reception and access control for contractors. By offering a single, integrated service, HomeHero aims to streamline home management for tenants, homeowners, and property managers, enabling users to coordinate utilities, repairs, and routine chores from one interface with scalable, cloud-enabled tools.

Primer

Series A in 2020
Primer API Limited operates an online platform that consolidates fragmented payment ecosystems for e-commerce merchants and online payment facilitators. Founded in 2019 and based in London, the company provides solutions to optimize both front and backend payment flows, aiming to enhance authorization rates, minimize costs, and facilitate market expansion. Primer enables users to seamlessly connect with various third-party services, including payment service providers, fraud detection systems, and subscription billing engines. Its platform allows merchants to easily integrate new payment methods, streamline fraud mitigation, and implement sophisticated transaction routing without requiring coding skills. Through these capabilities, Primer enhances the overall commerce experience for customers and empowers businesses to improve their operational efficiency.

Greyparrot

Seed Round in 2020
Greyparrot applies artificial intelligence to enhance global recycling efficiency. Its platform, Greyparrot Analyzer and Sync API, provides real-time insights on waste composition across multiple locations, enabling stakeholders to increase recycling rates, optimize resource recovery, and reduce environmental impact.

Corlieve Therapeutics

Seed Round in 2020
Corlieve Therapeutics SAS is a biotechnology company based in Paris, France, dedicated to developing innovative therapeutic options for patients suffering from severe neurological disorders. Founded in 2019, the company focuses on a lead project that targets aberrantly expressed kainate receptors in the hippocampus of patients with temporal lobe epilepsy (TLE) through a gene therapy approach. This novel AAV gene therapy program aims to address refractory TLE, leveraging scientific research from notable institutions such as INSERM, CNRS, Aix Marseille University, and the University of Bordeaux. By advancing its therapeutic strategies, Corlieve Therapeutics seeks to enhance the quality of life for individuals impacted by these challenging conditions.

Araris Biotech

Seed Round in 2020
Araris Biotech AG is a biotechnology start-up based in Zurich, Switzerland, founded in 2019. The company specializes in developing antibody-drug conjugate (ADC) linker technology aimed at enhancing chemotherapy by delivering chemotherapeutic agents directly to targeted antibodies. This innovative platform allows for the rapid production of high-quality ADCs without the need for extensive engineering of antibodies or cell lines, enabling the use of readily available antibodies. The site-specific conjugation process facilitates swift manufacturing and reliable quality control, supporting the creation of safe and potent drugs for various diseases. Araris Biotech's technology is protected by two patents, underscoring its commitment to advancing cancer treatment through improved safety and tolerability for patients.

NativeWaves

Series A in 2020
NativeWaves is a technology company that specializes in audio synchronization and streaming solutions aimed at enhancing live event viewing experiences. By collaborating with partners, the company identifies compelling content and develops tools that allow for personalized and synchronized delivery of multimedia content across multiple screens. NativeWaves' software effectively translates movies, sports events, and videos into various languages without causing interruptions or synchronization delays. Additionally, it provides real-time statistics and insights on alternate screens, enabling viewers to engage with their favorite events in preferred languages and formats. The company's commitment to delivering intuitive and user-friendly technology ensures that existing workflows remain unchanged while enhancing the overall experience for audiences worldwide.

Vico Therapeutics

Series A in 2020
Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.

Artiria Medical

Series A in 2020
Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.

doctorly

Seed Round in 2020
Doctorly is a health tech company that provides a cloud-based practice management platform for doctors to run their entire practice in one system. The platform includes digital booking, video conferencing, electronic health records, and patient health analysis, and offers a connected patient app along with an integration platform to natively connect tools and workflows within the healthcare ecosystem. The goal is to save doctors time, reduce costs, and increase efficiency while enabling broader connectivity with partners and services. Founded in 2017 and based in Berlin, Germany.

Agro.Club

Seed Round in 2020
Agro.Club is a full-stack B2B global marketplace focused on the agricultural sector, operating primarily in Europe, South America, and North America. The company aims to enhance the efficiency and sustainability of the food supply chain by leveraging technology to connect various stakeholders in the agriculture value chain. With a user base exceeding 40,000 farmers and thousands of grain companies, Agro.Club employs advanced analytics and algorithms to ensure transparency in the market and to rapidly match supply with demand. Its custom-built platform facilitates the entire transaction process, including quality control, KYC compliance, logistics, and financing, making it a unique player in the global grain marketplace. Agro.Club is already operationally profitable, reflecting its effective approach to addressing the complexities of the agricultural supply chain.

Sympatient

Seed Round in 2020
Sympatient develops virtual reality-based psychotherapy treatments for anxiety disorders. It offers apps like Otemi for stress management and Invirto for independent anxiety therapy at home. The company combines digital therapeutics with therapist sessions, providing accessible personalized mental health care.

Accure Therapeutics

Series A in 2020
Accure Therapeutics S.L. is a pharmaceutical company based in Barcelona, Spain, focused on the development, production, and marketing of drugs aimed at treating central nervous system (CNS) diseases. As a clinical-stage research and development entity, Accure Therapeutics specializes in creating disease-modifying therapies for both severe orphan and non-orphan CNS disorders. The company is committed to accelerating the transition to effective treatments for disabling brain conditions, thereby enabling healthcare professionals to better address the complexities of CNS-related illnesses.

Schüttflix

Venture Round in 2020
Founded in 2018, Schüttflix is a digital platform that facilitates the delivery of bulk construction materials such as sand, crushed rock, and gravel. It connects suppliers, customers, truckers, waste disposal companies, and freight forwarders within the construction industry.

Planetly

Seed Round in 2020
Planetly is a Berlin-based software company specializing in intelligent carbon management. It provides a platform that automates the process from data collection to reduction strategies and offsetting measures, helping businesses gain transparency into their carbon footprint and take pragmatic action against climate change. Planetly serves various sectors including banking, insurance, manufacturing, retail, and IT, assisting them in analyzing, reducing, and offsetting their organizational carbon footprints.

CALYXHA Biotechnologies GmbH

Seed Round in 2020
CALYXHA Biotechnologies GmbH is a biotechnology company based in Vienna, Austria, established in 2019. The company focuses on developing innovative therapies aimed at addressing tissue degeneration, which is a primary factor in various significant human diseases. Through its research and development efforts, CALYXHA seeks to create solutions that could potentially transform treatment options for patients suffering from conditions linked to tissue degeneration.

Superscript

Series A in 2020
Superscript is a digital insurance broker offering tailored solutions for businesses of all sizes. Through its self-serve online platform, small businesses can efficiently manage their insurance needs. Meanwhile, Superscript's tech-specialist brokerage team provides customized cover for innovative companies with complex risks.

Coindirect

Venture Round in 2020
Coindirect is a cryptocurrency trading platform focused on accelerating adoption across Africa and other emerging markets. Founded by a team from South Africa, it offers an end-to-end solution that allows users to buy and sell various cryptocurrencies directly on a peer-to-peer marketplace with 0% transaction fees. Users can engage in transactions using multiple payment methods, including credit cards, local bank transfers, and PayPal. Coindirect supports over 40 cryptocurrencies and altcoins, including ERC-20 tokens, and provides 15 trading pairs on its exchange platform. The service caters to a wide range of users, from first-time buyers to experienced investors, enabling them to securely manage their assets in one place. Additionally, Coindirect offers access to its underlying technology via an API for other fintech services. By bridging the gap between traditional finance and the cryptocurrency landscape, Coindirect aims to facilitate mainstream adoption of digital currencies.

Motorpharma

Seed Round in 2020
Motorpharma is a biotechnology company focused on developing drug candidates that target motor proteins, specifically to address spasticity in patients. The company provides drug development services that facilitate research and enhance treatment options for healthcare professionals. Its innovative myosin inhibitors are designed to alleviate the symptoms of spasticity, particularly in individuals recovering from strokes. By improving the accessibility and effectiveness of these treatments, Motorpharma aims to support healthcare providers in delivering better care to their patients.

Motley London

Venture Round in 2020
Motley London Ltd, established in 2017 and headquartered in London, specializes in designing, manufacturing, and retailing jewelry. The company offers a wide range of products including earrings, necklaces, rings, bracelets, and charms, all sold exclusively online. Motley London collaborates with renowned jewelry designers from around the world to create its collections, aiming to provide customers with unique, high-quality pieces.

Black Insurance

Venture Round in 2020
Black Insurance is an innovative insurance platform that leverages blockchain technology to streamline the insurance industry. By connecting local managing general agents (MGAs), brokers, and agents directly with capital, Black removes traditional insurance companies from the value chain. This model allows local agents to design, price, and sell insurance products tailored to their markets while handling claims efficiently. The use of blockchain not only minimizes expenses and delays associated with conventional insurance processes but also enhances scalability by decentralizing business decisions, bringing them closer to the end customers. Black Insurance aims to transform the insurance landscape by offering a more agile and responsive alternative to traditional methods.

Intercontinental Capital

Seed Round in 2020
Intercontinental Capital is a leading global financial advisory firm specializing in cross-border transactions.

DRUID AI

Seed Round in 2019
Founded in 2018, DRUID AI is a leading enterprise AI platform that empowers teams to rapidly develop and deploy intelligent agents, knowledge bases, and apps. Its AI Agents facilitate personalized, secure interactions across channels, integrating seamlessly with existing systems and RPA technologies. With over 200 partners and 300 clients worldwide, DRUID AI aims to provide each employee with an intelligent virtual assistant.

Aleva Neurotherapeutics

Series E in 2019
Aleva Neurotherapeutics SA is a Swiss company specializing in the development of advanced implantable deep brain stimulation (DBS) systems. Founded in 2008 and based in Lausanne, Aleva focuses on creating next-generation neurostimulation devices that utilize microelectromechanical systems (MEMS) technology. Its flagship product, directSTIM, features an array of directional microelectrodes that enable precise electrical stimulation, enhancing the efficacy of DBS therapy for conditions such as Parkinson's disease and essential tremor. In addition, Aleva has developed spiderSTIM, a diagnostic system that maps three-dimensional brain targets to optimize stimulation, and cortiSTIM, designed for cortical stimulation. The company is committed to maximizing the potential of its technology by launching a series of therapeutic products while carefully managing development risks. Aleva Neurotherapeutics is ISO13485 certified, underscoring its dedication to quality and safety in the medical device sector.

ImCheck Therapeutics

Series B in 2019
Founded in 2015, ImCheck Therapeutics specializes in developing immunotherapeutics targeting members of the butyrophilin super-family for treating a range of autoimmune diseases, with a primary focus on immuno-oncology.

Peerbridge Health

Venture Round in 2019
Peerbridge Health Inc. is a digital health company specializing in advanced remote monitoring solutions for vital signs. The company develops a wireless electrocardiogram (ECG) monitor, Peerbridge Cor, which provides real-time heart data to physicians and allows for continuous arrhythmia detection over seven days. In addition to Peerbridge Cor, the company offers products like Peerbridge CorHRV and Peerbridge Cor+, which monitor a range of vital signs including heart rate rhythm, respiratory rate, temperature, oxygen saturation, and heart rate variability. Founded in 2012 in New York by Angelo Acquista, Peerbridge Health holds two pioneering patents for medical-grade monitoring of vital signs, with additional patents pending. By enhancing the accuracy and affordability of diagnoses, Peerbridge Health aims to improve patient outcomes and support various medical, wellness, and performance-based monitoring needs.

Yonder AG

Seed Round in 2019
Yonder AG is a Swiss company based in Zurich, founded in 2015, that specializes in documentation-as-a-service (DaaS) solutions. The company's flagship offering, Yonder Mind, is an application designed for efficient information management, enabling organizations to create, maintain, and deliver information effectively to users. Yonder AG focuses on streamlining the documentation process by providing shorter, more relevant documents and manageable revisions, alongside services for document content creation and conversion. Through its innovative solutions, Yonder AG aims to enhance the way businesses handle their information needs.

Orchestra BioMed

Series B in 2019
Orchestra BioMed is a biomedical innovation company based in New Hope, Pennsylvania, founded in 2017. The company specializes in developing high-impact therapeutic solutions for major medical conditions, with a primary focus on cardiovascular diseases, which are responsible for approximately 31% of global deaths annually. Orchestra BioMed's business model involves strategic partnerships with medical device companies to accelerate the commercialization of its products. Its key product candidates include BackBeat Cardiac Neuromodulation Therapy for hypertension and Virtue Sirolimus AngioInfusionBalloon for atherosclerotic artery disease.

NovaGo Therapeutics

Series A in 2019
NovaGo Therapeutics AG is a biotechnology company based in Schlieren, Switzerland, focused on researching and developing human antibody therapeutics aimed at treating cerebral stroke and spinal cord injury. Founded in 2015, the company specializes in recombinant human monoclonal antibodies that target the nerve outgrowth inhibitor Nogo-A, with the goal of stimulating nerve repair and regeneration. NovaGo Therapeutics has established a strategic partnership with Neurimmune Holding AG, which allows access to a unique class of human-derived antibodies with promising therapeutic properties derived from their Reverse Translational Medicine™ technology platform. Through its innovative approach, NovaGo Therapeutics seeks to advance treatment options for patients suffering from neurological injuries.

Sonect

Venture Round in 2019
Sonect operates a location-based matchmaking platform that connects individuals needing cash with local businesses willing to facilitate cash withdrawals. This enables shops to earn additional income and attract customers, while users can withdraw cash conveniently without fees. The service also benefits banks by reducing ATM operation costs and providing access to new markets.

Doctify

Venture Round in 2019
Doctify Limited is a HealthTech company that operates an online platform enabling patients to search, compare, and book appointments with healthcare specialists across various medical fields, including cardiology, dermatology, and orthopedics, among others. Founded in 2014 and headquartered in London, the platform allows users to filter their options based on verified patient reviews, distance, and availability, ensuring they find the most suitable healthcare provider for their needs. In addition to serving patients, Doctify offers tools for healthcare professionals to manage their practices, enhance patient engagement, collect feedback, and reduce appointment no-shows through automated reminders. The company has expanded into five markets and continues to pursue aggressive growth plans, focusing on improving the overall patient experience by leveraging real-time insights from patient feedback.

Mytos

Seed Round in 2019
Mytos is a company focused on creating a fully automated cell manufacturing platform tailored for the biotechnology sector, particularly in drug development. The platform utilizes advanced automation technology to streamline the production of human cells, allowing pharmaceutical and biotech companies to optimize their cell culture processes. By enabling scientists to easily modify culturing protocols, Mytos facilitates more rapid advancements in cell growth and overall efficiency in research and development. This innovative approach aims to enhance the capabilities of businesses in the drug development industry by providing a sophisticated solution for cell production.

medHF

Venture Round in 2019
medHF performs Human Factors research at Formative and Validation stages of medical device / combination product development.

BaseLaunch

Seed Round in 2019
BaseLaunch is a venture builder firm located in Basel, Switzerland, focused on launching and developing startups across various therapeutic sectors, including oncology, immunology, and cardiovascular health. The program spans 15 months and is divided into two phases, providing non-dilutive funding and access to a network of leading healthcare partners. Participants benefit from the expertise of seasoned advisors and state-of-the-art infrastructure, while being integrated into Basel's vibrant biotech ecosystem. BaseLaunch is supported by prominent industry leaders such as Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche, and Roivant Sciences, along with various public and private collaborators.

YoFumo

Venture Round in 2019
YoFumo Technologies Inc. is a Denver, Colorado-based company that specializes in manufacturing innovative solutions for the cannabis industry. Established in 2015, it focuses on post-harvest processing and storage technologies, offering products such as Yofumo Pro+, a comprehensive solution for curing, aging, and managing cannabis after trimming, and the Quad System, which addresses post-harvest processing needs. Additionally, YoFumo Pro provides environmental control and monitoring capabilities for cannabis handling. The company's patent-pending technology enables effective decontamination and curation, allowing for antimicrobial treatment and terpene management without the use of harmful chemicals, thereby enhancing product consistency and quality.

Casafy

Seed Round in 2018
In a constantly changing society, speed and assertiveness speak louder. Pocket devices help us to make decisions and save us time in choosing the right ones. We're constant updated about our favorite shows, favorite artists, fancy restaurants. The time has come for this to be replicated to our favorite neighborhood, our favorite city, our dream home/property. In an increasingly technological market, we believe in using artificial intelligence to provide an intelligent connection between SELLER and SEEKERS. Thinking this way, CASAFY brings to the market a POWERFUL App, which offers a fast and intelligent connection between both. The right properties for the right customer, at the right time in their lives. All this easily and accessible at the touch of a finger. This puts the real estate market once and for all in the 21st century, meaning no paperwork, making life easier for those who sell, those who intermediate and those who buy. Thus, we can offer a new proposal reaching from A-Z, from the low cost to the high luxury customer. Imagine seeing only what you want, without needing filters or wasting months searching for the ideal property. We do it for you, without you realizing it, because we have a clean interface with no advertisements. We aim to go where the eyes can't, using imagination and innovation to transform the reality of the entire real estate chain, from the construction company, through the intermediation of real estate and brokers, to the person who acquires the property . Casafy is online in Brazil, with over 1.2 million real estate sale and rental offers published!

Spiral Therapeutics

Series A in 2018
Spiral Therapeutics, Inc. is a clinical-stage pharmaceutical company founded in 2016 and based in San Francisco, California. The company specializes in developing novel therapies for inner ear disorders, particularly focusing on acute and subacute hearing loss as well as balance disorders caused by neurodegenerative, inflammatory, or vascular issues. Spiral Therapeutics employs a unique platform that aims to deliver targeted drug therapies directly to the inner ear, optimizing treatment effectiveness by ensuring that the right medications are administered at the right location and for the appropriate duration. Through its innovative approach, the company seeks to provide patients with effective treatments for hearing loss and related conditions.

CheckYeti.com

Series A in 2018
CheckYeti GmbH is an online platform and mobile application that facilitates the booking of ski instructors, ski schools, and mountain guides across various outdoor activities. Founded in 2014 and based in Vienna, Austria, CheckYeti offers users access to over 12,000 activity options in more than 1,000 mountain and beach destinations throughout Europe. The platform allows users to compare different instructors and guides based on reviews and pricing, enabling them to choose their preferred options. Additionally, it provides instructors and guides with enhanced visibility and the ability to interact directly with customers, as well as receive individual feedback. This comprehensive service caters to both winter and summer activities, including skiing, snowboarding, rafting, paragliding, and more, making it a valuable resource for holidaymakers and outdoor enthusiasts.

ReBio

Seed Round in 2018
Rebio Technologies Limited, established in 2014 and based in Cranleigh, UK, is a biomedical company specializing in the development and manufacturing of bioresorbable polymers for medical devices and pharmaceuticals. It formulates and supplies multiple grades of these materials, catering to both medical device and active drug programs. Rebio's unique selling proposition lies in its proprietary polymer technology, which enables the efficient and cost-effective production of high-value chemicals through fermentation, addressing safety and efficacy challenges in sustained release approaches. The company's offerings include active drug programs and active medical device programs, with a focus on renewable resources and innovative solutions for manufacturing industries.

PUBLIC Group International

Seed Round in 2018
PUBLIC Group International provides business mentorship and consulting services to technology startups aiming to collaborate more deeply with UK public services. Its mission is to facilitate partnerships between governments, startups, and investors, breaking down barriers to improve citizens' lives.

System1 Biosciences

Series A in 2018
System1 Biosciences, Inc. is a San Francisco-based neurotherapeutics company established in 2017, specializing in drug discovery for complex neurological and psychiatric disorders, including epilepsy, autism, and schizophrenia. The company employs phenotypic screening, integrating cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to uncover novel characterizations of diseases. This innovative approach allows System1 to identify "deep phenotypes," which are utilized to discover new therapeutic targets and drug treatments, addressing gaps in traditional discovery techniques that have struggled with these challenging conditions.

Veesion

Seed Round in 2018
Veesion is a technology company specializing in gesture recognition for real-time detection of shoplifting within the retail sector. Founded in 2018 and based in Paris, France, Veesion utilizes deep learning algorithms to analyze footage from security cameras, identifying gestures indicative of theft. The system autonomously generates alerts that are sent to human operators for confirmation and subsequent action. This innovative software can be integrated with existing surveillance systems, allowing retailers and distributors to enhance their security measures while optimizing the allocation of security personnel. By providing an ethical and effective solution to combat shoplifting, Veesion is reshaping the standards of retail security.

GotCourts

Seed Round in 2018
GotCourts Ltd is a software as a service (SaaS) platform based in Zurich, Switzerland, that specializes in the online community for racquet sports enthusiasts. Established in 2014, GotCourts provides tools for players, coaches, and court operators, facilitating the booking of courts and coaching services. The platform allows users to find playing partners, track their progress, and stay connected with fellow racquet sport participants. By aiming to become a comprehensive hub for tennis and other racquet sports, GotCourts enhances the experience for sports lovers, streamlining processes and unlocking the potential of the racquet sports community.

Lava Therapeutics

Series A in 2018
Founded in 2016 and headquartered in Utrecht, the Netherlands, Lava Therapeutics is a biotechnology company specializing in the development of proprietary Vγ9Vδ2 T-cell engagers for immune oncology. Its platform focuses on creating bispecific antibodies to engage gamma-delta T cells for treating hematological and solid cancers.

Wagz

Venture Round in 2018
Wagz, Inc. is a pet technology company based in Portsmouth, New Hampshire, specializing in smart collars for dogs. Founded in 2015, the company offers the Wagz Collar, which combines GPS tracking, health monitoring, and location enforcement to keep dogs safe and connected with their owners. The collar features an activity monitor that tracks health and behavior, an LED light for visibility, and a high-definition live streaming camera that can be activated remotely or by bark detection. Additionally, Wagz provides the Wagz Serve Smart Feeder, which ensures dogs receive the proper nutrition at designated times, and mobile applications that allow users to manage collar settings, record medical data, and engage with a community of fellow dog owners. Wagz products are available through various resellers in the United States and online, catering to the needs of modern pet owners.

Houst

Series A in 2018
Houst, formerly known as Airsorted, is a short-term rental management service based in London, U.K. Founded in 2015, the company specializes in providing a comprehensive platform for homeowners looking to maximize their rental income while minimizing the complexities associated with short-let hosting. Houst manages various aspects of property letting, including listing creation, pricing optimization, marketing, and guest management. By automating these processes, the company aims to deliver a hassle-free experience for homeowners, allowing them to achieve higher rental yields without the stress of day-to-day operations. With a mission to simplify home-sharing, Houst caters to both individual homeowners and the broader market by promoting efficient and effective rental practices.

NRx Pharmaceuticals

Series C in 2018
NRx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative therapeutics for central nervous system disorders and life-threatening pulmonary diseases. The company aims to address critical health challenges by researching and scaling solutions for conditions that often remain untreated. Notably, NRx has announced the commercialization of ZYESAMI (Aviptadil), which targets COVID-related respiratory failure. Additionally, the company is advancing NRX-100/101, a pioneering sequential drug regimen designed for the treatment of bipolar depression in patients experiencing acute suicidal ideation and behavior. In a significant development, NRx was granted exclusive worldwide rights to develop and market the BriLife COVID vaccine by the Government of Israel, further expanding its portfolio in the fight against serious health threats.

Heist Studios

Series B in 2018
Heist Studios Limited is a London-based company that specializes in manufacturing tights for women. Founded in 2015, the brand aims to redefine bodywear by innovating the traditional tight. Heist Studios operates primarily through online sales, rapidly gaining popularity and achieving significant sales milestones, including over 100,000 pairs sold within its first year of operation. The company has experienced substantial growth, with a monthly increase of 25% in sales. It has garnered notable recognition in the fashion industry, with endorsements from prominent publications such as Vogue and STYLE magazine, which praised its quality and innovation in the luxury tights market.

UV Light Care

Venture Round in 2018
UV Light Care, Inc. is a medtech company based in Boston, Massachusetts, that focuses on the development and application of ultraviolet (UV) light technology for disinfection and other medical purposes. Incorporated in 2015, the company has specialized in creating disinfection solutions aimed particularly at vascular access devices and indwelling catheters, addressing critical needs within the medical community. Through its innovative technology, UV Light Care aims to enhance patient safety and improve infection control practices in healthcare settings.

Triple Dragon

Seed Round in 2018
Triple Dragon is a financial services provider specializing in facilitating the growth of game and application developers, as well as publishers, through user acquisition loans. The company offers a range of flexible investment products designed to fund marketing campaigns and user acquisition efforts, allowing clients to expand their install base and boost revenue without relinquishing equity. By supporting the financing needs of gaming technology stakeholders, Triple Dragon helps its clients launch and scale their projects effectively, contributing to their overall business growth.

Vertus Capital

Seed Round in 2018
Vertus Capital provides capital to help facilitate the sale and purchase of advice firms.

Loma

Seed Round in 2018
Loma offers a search platform that aggregates secondhand, rental, and repair sites, connecting brands with customers and facilitating sustainable consumption. Its key innovation is an AI-driven resale pricing prediction tool, which accurately forecasts the resale value of products down to the model number, helping businesses optimize their resale strategies.

DF Capital

Seed Round in 2018
DF Capital specializes in building relationships with manufacturers and offering working capital solutions throughout supply chains. By providing flexible finance products, DF Capital assists businesses in driving their growth and aligning their cash cycle with lending terms. This approach allows companies to effectively manage cash flow and meet their financial needs for continued expansion and success.

AdaptHealth

Venture Round in 2017
AdaptHealth is a provider of patient-centered healthcare-at-home solutions, specializing in home medical equipment (HME), medical supplies, and associated services. The company distributes a wide range of clinically driven products designed to support patients in living independently, including sleep and respiratory therapy equipment, mobility aids, wound care supplies, and nutrition services. AdaptHealth also offers vital services such as continuous glucose monitoring and insulin pumps for diabetes management, as well as oxygen and chronic therapy services. Founded in 2012 and headquartered in Phoenixville, Pennsylvania, the company serves patients and healthcare institutions across several states, including Pennsylvania, New Jersey, New York, Maryland, and Delaware. Additionally, AdaptHealth provides online bill payment services to assist patients in managing their medical equipment expenses.

omicX

Venture Round in 2017
omicX is a company based in Le Petit Quevilly, France, that operates a bioinformatics platform designed to facilitate access to biotechnology tools. Established in 2012, omicX aims to harness the growing collective intelligence in bioinformatics to leverage biological Big Data for various applications across biotechnology, life sciences, medicine, agriculture, and industry. Its primary offering, OMICtools, serves as a valuable resource for scientists and developers, providing information on tools for storing, processing, and sharing significant volumes of biological data. The platform also enables users to engage with the scientific community by posting questions, sharing expertise, and providing feedback on available tools. This innovative approach has positioned omicX as a trusted leader and global reference in the bioinformatics field, attracting users from prestigious universities, medical institutions, pharmaceutical companies, and the biotech industry.

Bricksave

Seed Round in 2017
Bricksave is a global real estate investment platform that enables users to invest in properties worldwide from as little as $1,000. It offers a curated selection of unique properties in prime locations, with investors benefiting from rental income and capital gains. Bricksave manages the properties continuously, ensuring hassle-free investments.

Frontier Car Group

Series A in 2017
Frontier Car Group is a Berlin-based startup focused on developing and operating used automotive marketplaces in emerging markets, including Nigeria, Mexico, Argentina, Colombia, Chile, Pakistan, and Indonesia. The company aims to simplify the process of buying and selling used cars through its online platform, which features a digital quote engine that provides instant pricing for vehicles. This technology not only enhances the efficiency of transactions but also facilitates quick vehicle inspections at designated locations. By leveraging innovative business models and infrastructure, Frontier Car Group is able to create value for all stakeholders involved in the used car market. Additionally, the company is engaged in joint ventures with OLX in India and Poland, further expanding its reach and impact in the automotive sector.

Mavencare

Series A in 2017
Mavencare specializes in home care services, focusing on enabling seniors to safely age in place. They offer a range of services including companionship, housekeeping, meal preparation, personal care, nursing care, and specialized care. Mavencare leverages technology to optimize caregiver hiring, match clients with caregivers, collect community-based data, and identify potential risks using machine learning algorithms.

PlayStack

Venture Round in 2017
PlayStack is a game publishing company that supports developers with financing, publishing expertise, and technology to build a strong gaming audience and community. It provides funding, strategic guidance, and promotional resources to help creators bring concepts to life, fund and publish titles, and grow worldwide IP audiences.

Homeshift

Venture Round in 2017
Homeshift builds a simple online dashboard that lets users see their existing services. They design homes and services from scratch. They provide services in internet, energy, water, and council.

Iproteos

Venture Round in 2016
Iproteos is a biotechnology company specializing in the research and development of innovative therapeutic strategies aimed at modulating protein-ligand and protein-protein interactions through the use of peptidomimetics. The company employs its proprietary IPRO technology platform to discover and develop therapeutic agents targeting diseases of the central nervous system, including schizophrenia, epilepsy, and pediatric cancer. Iproteos focuses on third-generation drugs that leverage advanced understanding of protein interactions to create effective treatments. With expertise in peptidomimetics, Iproteos positions itself as a valuable partner for organizations seeking to advance their own therapeutic targets in the biomedical field.

KB Medical

Series B in 2016
KB Medical SA is a Swiss company that specializes in the design, development, and commercialization of robotic assistance systems for the healthcare industry, particularly in spinal surgery. Founded in 2012 and based in Lausanne, Switzerland, the company is known for its AQrate robotic system, which assists surgeons during spinal fusion procedures. The technology behind the AQrate system enhances surgical precision, reduces radiation exposure for operating room teams, and aims to improve patient outcomes and quality of life following surgery. KB Medical is certified under ISO 13485 for the design and manufacture of its robotic systems, highlighting its commitment to high-quality medical devices. As of 2017, KB Medical operates as a subsidiary of Globus Medical, Inc.

Pockit

Series A in 2016
Pockit Limited is a fintech company based in London, United Kingdom, that offers financial services primarily to individuals who are often excluded or underserved by traditional banks. Established in 2010, Pockit provides a prepaid MasterCard along with an online account that enables customers to receive their wages and benefits directly. Users can fund their accounts through various methods, including debit cards and bank transfers, at multiple locations across the UK. The company also offers a mobile application for both iPhone and Android devices, allowing customers to manage their finances conveniently. Pockit's services extend to in-store, online, and international usability, as well as cashback savings solutions, making it a comprehensive option for those seeking accessible banking alternatives.

3Derm Systems

Series A in 2016
3Derm Systems, Inc., based in Boston, Massachusetts, is a pioneering company in 3D dermatology that provides a specialized handheld skin imager and cloud-based software designed for capturing, storing, and transmitting high-resolution 3D images of the skin. Established in 2011, the company enables non-dermatologists to take clinical-quality skin images remotely, facilitating efficient monitoring of skin lesions by dermatologists. This innovative approach reduces healthcare costs, shortens wait times, and enhances access to dermatological care, particularly for the two million Americans diagnosed with skin cancer annually. By allowing patients to capture images from the comfort of their homes and upload them for review, 3Derm helps prioritize in-office appointments for those with more concerning conditions. The company's technology aims to transform teledermatology, offering a cost-effective solution that maintains the continuity of care with local dermatologists while ensuring high diagnostic quality. As of August 2020, 3Derm operates as a subsidiary of Digital Diagnostics, Inc.

Memory

Venture Round in 2016
Memory AS, a Norwegian startup based in Oslo, specializes in developing innovative tools aimed at enhancing productivity in the workplace. Established in 2013, the company is known for its flagship product, Timely, which is recognized as the world's first AI-powered time tracking and planning tool. In addition to Timely, Memory has launched Dewo, a personal assistant designed to facilitate deep work. By leveraging artificial general intelligence, Memory AS focuses on creating solutions that promote a better work-life integration and improve overall efficiency.

Integrity Implants

Venture Round in 2016
Integrity Implants focuses in developing unique expandable interbody technology. The company's goal is to make the lives of customers better through advances in minimally invasive procedures. Integrity Implants constructs innovative technologies and products that can contribute to the enhancement of patient and hospital outcomes as it pertains to orthopedics and spine. Integrity Implants was founded 2016 and is headquarters Jupiter, Florida.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.